Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Infect Chemother ; 27(2): 387-389, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-957212

ABSTRACT

The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity has been depressed (CD4+T cell <100/µl) due to advanced malignant lymphoma and chemotherapy which had been completed 4 months prior to the onset of symptoms of COVID-19. We administered several treatments against COVID-19, however the results of Polymerase Chain Reaction (PCR) from nasopharyngeal specimens remained positive to SARS-CoV-2 for 2 months. Moreover, virus isolation assays performed on Day 59 also remained positive. He was finally discharged on Day 69 with two consecutive negative PCR results for SARS-CoV-2. Immunocompromised status may prolong viral shedding and it is therefore important for the clinician to take into account this when assessing such patients.


Subject(s)
COVID-19/immunology , Immunocompromised Host , Lymphoma/complications , SARS-CoV-2/isolation & purification , Virus Shedding , Antiviral Agents/therapeutic use , COVID-19/complications , COVID-19/therapy , COVID-19/virology , Humans , Lymphoma/virology , Male , Middle Aged , Nasopharynx/virology , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL